Direct-to-consumer genetic testing services: policies and challenges

Camilla Fittipaldi Jales*, Pascal Borry

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The evolution of genetic technology allowed for the emergence of an industry through which private laboratories and companies began to market and offer genetic testing products directly to consumers. Direct-to-consumer (DTC) genetic testing can be defined as the sale, provision, or advertising of genetic tests outside the context of the healthcare system. Due to the concerns posed by DTC genetic testing, considerable discussion on this phenomenon has arisen among the scientific community, policy makers, and the general public. While an increasing range of DTC genetic tests is progressively available, the reality is that legislation and government oversight at international level is insufficient to monitor or provide regulatory control over these activities. Only through the promotion of the harmonization of practices, regulations, international cooperation among policy makers, and genetic literacy, among the media and the general public, will it be possible to overcome the challenges posed by DTC genetic testing services.
Original languageEnglish
Title of host publicationLegal and forensic medicine
EditorsRoy G. Beran
PublisherSpringer Berlin Heidelberg
Pages1583-1598
Number of pages16
ISBN (Electronic)9783642323386
ISBN (Print)9783642323379
DOIs
Publication statusPublished - 1 Jan 2013

Fingerprint

Dive into the research topics of 'Direct-to-consumer genetic testing services: policies and challenges'. Together they form a unique fingerprint.

Cite this